Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORE-001 oral lidocaine for increasing food intake in underweight older adults
NL-OMON60415Phase 2Not yet recruiting
- Sponsor
- Orexa
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Underweight comparing ORE-001 with Placebo (2 arms). Primary endpoints: Change from baseline in standardized lunch food intake on day 1 and Change from baseline in standardized lunch food intake on day 42. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Underweight
Beyond the preview
Go deeper on NL-OMON60415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60415.